Search Results

Safety and Efficacy Data Published for Teleflex's Manta Closure Device

July 12, 2019—Findings from SAFE MANTA, the pivotal clinical study to evaluate the safety and effectiveness of the Manta percutaneous vascular closure device (Teleflex), were published by David A. Wood, MD, et al in Circulation: Cardiovascular Interventions.

Teleflex’s MANTA ULTRA Study Begins Enrollment

June 22, 2022—Teleflex Incorporated announced that the first patient was enrolled in the MANTA ULTRA clinical study, which seeks to demonstrate the safety of ultrasound-guided closure with the company’s Manta vascular closure device without dependence on preprocedural depth-locator measurements.

Teleflex Manta Vascular Closure Device Approved in Canada

May 18, 2022—Teleflex Incorporated announced that it received Health Canada approval for the Manta vascular closure device, which is designed specifically for large-bore femoral arterial access site closure.

Enrollment Completed in Pivotal Trial of Essential Medical's Manta Large-Bore Vascular Closure Device

October 2, 2017—Essential Medical, Inc. announced the completion of enrollment in the United States pivotal trial of its Manta large-bore vascular closure device.

United States Pivotal Trial Begins for Essential Medical's Manta Vascular Closure Device

December 12, 2016–Essential Medical, Inc. announced the start of the MANTA United States pivotal trial for the company's Manta vascular closure device.

FDA Approves IDE for Trial of Essential Medical's Manta Large-Bore Vascular Closure Device

July 8, 2016—Essential Medical, Inc. announced that it has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to begin the United States clinical trial for Manta, the company’s large-bore vascular closure device.

­OpSens’ SavvyWire Included in Hemodynamics Substudy of COMPLETE TAVR

May 10, 2023—OpSens Inc., a Québec City, Canada–based company focused on optical technology with cardiology device applications, announced the inclusion of the company’s SavvyWire in the COMPLETE TAVR clinical study to investigate the impact of standardized invasive hemodynamics (SIH) during transcatheter aortic valve replacement (TAVR) procedures.

Results Presented From Pivotal Trial of Essential Medical's Manta Vascular Closure Device

June 25, 2018—Essential Medical, Inc. announced the results from the pivotal SAFE MANTA investigational device exemption (IDE) clinical trial, which is evaluating the company's Manta dedicated large-bore vascular closure device.

Cardiovascular Pioneer Edward B. Diethrich, MD, 1935–2017

February 28, 2017—Edward B. Diethrich, MD, a pioneer in noninvasive cardiovascular disease diagnosis and innovative surgical and minimally invasive treatments, succumbed to complications of a brain tumor on February 23 at the age of 81. Dr. Diethrich was an internationally esteemed cardiovascular surgeon, inventor, and philanthropist. He is survived by his wife of 61 years, Gloria, two children, and eight grandchildren. A celebration of his life will be planned in the near future. Details will be posted at drteddiethrich.com.